Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12 | 12 | 8 | 341 | 84 |
| Inventories | N/A | 50 | 50 | 50 | 586 |
| Other current assets | 9 | 56 | 12 | 2 | 0 |
| TOTAL | $21 | $118 | $70 | $393 | $670 |
| Non-Current Assets | |||||
| PPE Net | 10 | 15 | 22 | 28 | 2 |
| Intangibles | 0 | 0 | 2 | 6 | 22 |
| Other Non-Current Assets | 183 | 188 | 238 | 284 | 0 |
| TOTAL | $193 | $204 | $263 | $317 | $24 |
| Total Assets | $214 | $322 | $333 | $710 | $694 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,066 | 2,210 | 1,637 | 647 | 519 |
| Accounts payable and accrued liabilities | 2,477 | 1,253 | 328 | 40 | 16 |
| Accrued Expenses | N/A | N/A | 30 | 1 | 60 |
| Other current liabilities | 2 | 83 | 1 | 0 | 1 |
| TOTAL | $4,615 | $3,608 | $2,049 | $734 | $595 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 56 | 126 | 187 | 241 | 0 |
| TOTAL | $56 | $126 | $187 | $241 | $N/A |
| Total Liabilities | $4,671 | $3,734 | $2,236 | $975 | $595 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,605 | 1,224 | 1,068 | 932 | 881 |
| Common Shares | 0 | 0 | 0 | 4 | 4 |
| Retained earnings | -14,682 | -11,342 | -7,196 | -4,266 | -1,261 |
| TOTAL | $-4,458 | $-3,413 | $-1,903 | $-265 | $99 |
| Total Liabilities And Equity | $214 | $322 | $333 | $710 | $694 |